23andme founder net worth
23andMe is facing more than 30 lawsuits after a data breach last year exposed personal information from nearly 7 million customers' profiles.
Valued at $6 billion in 2021 when it went public, 23andMe now risks being delisted from the Nasdaq as its stock continues to trade below $1 a share.
Who really owns 23andMe?
Anne Wojcicki, the cofounder and CEO of 23andMe, owns 99.4 million shares of the merged company; with shares trading on the Nasdaq under the ticker “ME” at $13.40 as of 3:00pm EDT Thursday, her stake is worth approximately $1.3 billion.17 jui. 2021
Who is CEO of 23andMe?
Anne Wojcicki (Apr 2006–)Anne E.
Wojcicki (/wuːˈtʃɪtski/ woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe.
She founded the company in 2006 with Linda Avey and Paul Cusenza.
She is a co-founder and board member of the Breakthrough Prize.
Is 23andMe a Chinese company?
23andMe Holding Co. is a publicly trading personal genomics and biotechnology company based in South San Francisco, California.
Autres questions
23andMe Reports FY2022 Fourth Quarter and Full Year Financial
26 mai 2022 CEO and Co-Founder of 23andMe. ... (income) net other expense (income) |
23andMe Holding Co.
8 juil. 2021 “Founder Shares”); (iii) 5113 |
23andMe Holding Co.
10 sept. 2021 On September 10 2021 |
Form 424B3 for 23andme Holding Co filed 05/26/2022
27 mai 2022 We have a founder-led inclusive |
23andMe Holding Co.
21 oct. 2021 execution and delivery of this Agreement (a) the Founders have ... entity |
54 NOB HILL GAZETTE 1 MARCH 2022 Peter Fortenbaugh and
1 mars 2022 about her worth in the world ... in October 2021 to co-CEO |
2010 SUMMARY OF RESULTS
even if they have reliable income from for example |
Erratum: People
6 juin 2007 Kevin Krenitskyhas been appointed as CEO of ... 23andMe (Mountain View CA |
Inc. Magazine - October 2015
21 oct. 2015 ON THE COVER ELIZABETH HOLMES CEO AND FOUNDER OF THERANOS |
Female founders report
1 oct. 2019 Addidi Wealth. KATHRYN PARSONS. LAURA TENISON MBE. Co-Founder. Founder. DeCoded. JoJo Maman Bébé. COSMINA POPA. DEBBIE WOSSKOW OBE. |
Valley of the unicorns: consumer genomics, venture capital and
in Silicon Valley the relationship between moral worth and economic value is global in scale: co-founder Anne Wojicki declared that 23andme aimed to http ://www recode net/2016/4/4/11585828/23andme-anne-wojcicki-genomics- |
PEOPLE - Nature
Kevin Krenitskyhas been appointed as CEO of BioServe 23andMe (Mountain View, CA, USA) was married last month Mr Brin has a net worth estimated at |
Dissertation Unimi Final - AIR Unimi
decades created a changing bio-economy Genetic Testing 2010) In April 2006, Anne Wojcicki and Linda Avey co-founded 23andMe, Inc , launching |
TOMORROWS TITANS 2019 - The Hedge Fund Journal
1 août 2019 · concentration; a lower net exposure is a function of the long and short opportunity former partner of BTG Pactual and former CEO/CIO/head of asset com, Roku, Nutanix, AppNexus, Dataminr and 23andMe, among others |
Privacy, Personal Data, and Surveillance - The Carr Center for
26 fév 2021 · individuals with lower net worth can be targeted “FDA to 23andMe Founder Anne Wojcicki: Stop Marketing $99 DNA Test or Face Penalties |
Genetic Testing Meets Big Data: Tort and Contract Law Issues - CORE
See Sarah Zhang, 23andMe Ordered to Halt Sales of DNA Tests information ( even with his wife) until he had the chance to do more research demands a fiduciary duty interpretation because “[a] fiduciary relationship is one founded |
Document_8pdf - SECgov
funding, and I have been working without salary since joining Founded DNAPrint genomics in 1999 and served as the leader of this firm until 2008 I |
THE GIFT OF SPIT - The Digital Humanities Institute
11 juil 2012 · net published by 23andMe researchers, including two articles order to generate economic value and co-founder of Google, Sergey Brin |
Rising to the data challenge - assetskpmg
Caroline co-founded and global Pharmaceutical and Bio-technology clients and helping them address their 10 GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines, GSK press release, |